Fundz

Who to call at Dynavax Technologies Corporation, and when

Fundz watches for the moments Dynavax Technologies Corporation starts buying, and tells you who to reach.

  • An alert the day Dynavax Technologies Corporation raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Dynavax Technologies Corporation, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Dynavax Technologies Corporation. With Fundz connected, it knows.

See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2
Back to SEC Filings
Executive ChangeItem 5.02 · 8-KMEDIUM RiskMixed

Dynavax Technologies Corporation

A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.

Filed: Oct 16, 2025CIK: 0001029142Health Care
View on SEC.gov

2 executive changes at DYNAVAX TECHNOLOGIES in the last 90 days. Clusters like this usually mean more senior seats open over the next few months.

The seat is still open. No replacement has been named 373 days after this filing.

See every company with multiple executive changes →

AI Executive Summary

AI-powered analysis of 8-K filing content

Dynavax's Board approved an internal management realignment: David F. Novack moves from President and COO to SVP and COO effective January 1, 2026, and the Board removed Chief Medical Officer Robert Janssen, M.D., whose employment ends by March 2, 2026 or earlier if a successor is hired. The CMO transition puts clinical leadership in flux while the company searches for a replacement.

Key Takeaways

Dynavax removed Robert Janssen, M.D. from his CMO and SVP, Clinical Development, Medical and Regulatory Affairs roles, with employment ending on the earlier of a successor's hiring or March 2, 2026.

The Company is actively searching for a new Chief Medical Officer, so clinical development and regulatory leadership will change within months.

3 more takeaways

Related Filings (2)

2 more filings from Dynavax Technologies Corporation in the last 90 days

Filing Overview

Form Type8-K
Filing DateOct 16, 2025
Item5.02
CategoryExecutive Change
CIK0001029142
Accession #0001193125-25-240766
Risk LevelMEDIUM
SentimentMixed
Signalrisk
Topics
executive departureleadership transition

What This Means

A senior executive (CEO, CFO, etc.) has joined, departed, or changed roles. Leadership changes can significantly impact strategy.
View Full Filing on SEC.govBrowse More Filings

Dynavax Technologies Corporation filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

4 screens from a live account. No signup.